@article{CCO22320,
author = {Tianhong Li and Weijie Ma and Eddie C. Tian},
title = {Ensartinib (X-396): what does it add for patients with ALK-rearranged NSCLC},
journal = {Chinese Clinical Oncology},
volume = {8},
number = {Suppl 1},
year = {2018},
keywords = {},
abstract = {Rearrangements of the anaplastic lymphoma kinase (ALK) gene were first identified in 2007 and occur in 3 to 5% of all patients with advanced non-small cell lung cancer (NSCLC) (1).},
issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/22320}
}